Burleson & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $9.5M | Buy |
25,979
+232
| +0.9% | +$84.9K | 2.37% | 10 |
|
|
2022
Q3 | $8.33M | Buy |
25,747
+295
| +1% | +$95.4K | 1.79% | 16 |
|
|
2022
Q2 | $8.25M | Sell |
25,452
-339
| -1% | -$110K | 1.79% | 15 |
|
|
2022
Q1 | $7.39M | Buy |
25,791
+9,977
| +63% | +$2.86M | 1.19% | 25 |
|
|
2021
Q4 | $4.37M | Sell |
15,814
-1,099
| -6% | -$304K | 0.64% | 34 |
|
|
2021
Q3 | $3.91M | Hold |
16,913
| – | – | 0.58% | 34 |
|
|
2021
Q2 | $3.88M | Buy |
16,913
+75
| +0.4% | +$17.2K | 0.57% | 39 |
|
|
2021
Q1 | $3.15M | Hold |
16,838
| – | – | 0.51% | 37 |
|
|
2020
Q4 | $2.84M | Hold |
16,838
| – | – | 0.49% | 38 |
|
|
2020
Q3 | $2.4M | Hold |
16,838
| – | – | 0.45% | 43 |
|
|
2020
Q2 | $2.58M | Hold |
16,838
| – | – | 0.56% | 40 |
|
|
2020
Q1 | $2.59M | Sell |
16,838
-42
| -0.2% | -$6.45K | 0.67% | 41 |
|
|
2019
Q4 | $2.39M | Buy |
16,880
+1
| +0% | +$142 | 0.67% | 41 |
|
|
2019
Q3 | $1.81M | Hold |
16,879
| – | – | 0.63% | 44 |
|
|
2019
Q2 | $1.87M | Hold |
16,879
| – | – | 0.79% | 37 |
|
|
2019
Q1 | $1.97M | Hold |
16,879
| – | – | 0.84% | 35 |
|
|
2018
Q4 | $2.07M | Sell |
16,879
-53
| -0.3% | -$6.5K | 1.07% | 25 |
|
|
2018
Q3 | $1.96M | Sell |
16,932
-422
| -2% | -$48.9K | 1.1% | 24 |
|
|
2018
Q2 | $1.48M | Sell |
17,354
-163
| -0.9% | -$13.9K | 0.86% | 38 |
|
|
2018
Q1 | $1.36M | Buy |
17,517
+4
| +0% | +$309 | 0.88% | 40 |
|
|
2017
Q4 | $1.48M | Buy |
+17,513
| New | +$1.48M | 0.95% | 34 |
|